Nam Duoc JSC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000NDC7
VND
170,000.00
58900 (53.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

18.77%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.0%
0%
25.0%
6 Months
40.61%
0%
40.61%
1 Year
13.33%
0%
13.33%
2 Years
17.24%
0%
17.24%
3 Years
61.75%
0%
61.75%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nam Duoc JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.90%
EBIT Growth (5y)
18.50%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
1.86
Tax Ratio
20.20%
Dividend Payout Ratio
15.45%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
37.96%
ROE (avg)
23.06%

Valuation key factors

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-1.19
EV to EBITDA
-1.10
EV to Capital Employed
-0.38
EV to Sales
-0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
18.77%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Nam Duoc JSC"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -8.47% vs 41.66% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -26.20% vs 91.85% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "830,308.50",
          "val2": "907,169.90",
          "chgp": "-8.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "128,147.70",
          "val2": "172,041.40",
          "chgp": "-25.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "96,490.30",
          "val2": "130,753.70",
          "chgp": "-26.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "142.00%",
          "val2": "178.20%",
          "chgp": "-3.62%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23stock-summary

Dec'23
Dec'22
Change(%)
Net Sales
830,308.50
907,169.90
-8.47%
Operating Profit (PBDIT) excl Other Income
128,147.70
172,041.40
-25.51%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
96,490.30
130,753.70
-26.20%
Operating Profit Margin (Excl OI)
142.00%
178.20%
-3.62%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -8.47% vs 41.66% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -26.20% vs 91.85% in Dec 2022

stock-summaryCompany CV
About Nam Duoc JSC stock-summary
stock-summary
Nam Duoc JSC
Pharmaceuticals & Biotechnology
Nam Duoc Joint Stock Company is a Vietnam-based company active in the pharmaceutical industry. The Company is engaged in the manufacturing, wholesale and retail trading of pharmaceutical products, including traditional medicine, Western medicine and function food and drinks. It is also involved in the trading and distribution of cosmetic products, pharmaceutical materials and medical equipment and supplies. In addition, the Company is engaged in the cultivation of medicinal herbs for traditional medicine manufacturing operations, as well as technology transfer and the provision of consulting and training services in the pharmaceutical industry.
Company Coordinates stock-summary
Company Details
Lot A7/D21, Cau Giay New Urban Residence, Dich Vong Hau Ward, Cau Giay District, HANOI None : None
stock-summary
Tel: 84 4 62691602
stock-summary
Registrar Details